IDEXX Laboratories (BSP:I1DX34) Current Accrued Expense : R$1,028 Mil (As of Mar. 2024)

View and export this data going back to 2020. Start your Free Trial

What is IDEXX Laboratories Current Accrued Expense?

IDEXX Laboratories's Current Accrued Expense for the quarter that ended in Mar. 2024 was R$1,028 Mil.

IDEXX Laboratories's quarterly Current Accrued Expense increased from Sep. 2023 (R$948 Mil) to Dec. 2023 (R$970 Mil) and increased from Dec. 2023 (R$970 Mil) to Mar. 2024 (R$1,028 Mil).

IDEXX Laboratories's annual Current Accrued Expense declined from Dec. 2021 (R$1,207 Mil) to Dec. 2022 (R$1,163 Mil) and declined from Dec. 2022 (R$1,163 Mil) to Dec. 2023 (R$970 Mil).

IDEXX Laboratories Current Accrued Expense Historical Data

The historical data trend for IDEXX Laboratories's Current Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

IDEXX Laboratories Current Accrued Expense Chart

IDEXX Laboratories Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Current Accrued Expense

Get a 7-Day Free Trial

613.11

965.09

1,207.02

1,162.88

970.07

IDEXX Laboratories Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Current Accrued Expense	Get a 7-Day Free Trial															1,045.44	835.28	948.26	970.07	1,027.97

IDEXX Laboratories Current Accrued Expense Calculation

Current Accrued Expense is the expense incurred during the accounting period, but not required to be paid until a later date. It includes compensation, interest, pensions and all other miscellaneous accruals reported by the company.

IDEXX Laboratories Current Accrued Expense Related Terms

Thank you for viewing the detailed overview of IDEXX Laboratories's Current Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

IDEXX Laboratories (BSP:I1DX34) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » IDEXX Laboratories Inc (BSP:I1DX34) » Definitions » Current Accrued Expense

Comparable Companies

Traded in Other Exchanges

IDXX:USA IDXX:Mexico IX1:Germany IDXX:Austria

Address

One IDEXX Drive, Westbrook, ME, USA, 04092

Website

https://www.idexx.com

Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx gets close to 40% of its revenue from outside the United States.

IDEXX Laboratories (BSP:I1DX34) Headlines

No Headlines